Target Name: FRMD8P1
NCBI ID: G83957
Review Report on FRMD8P1 Target / Biomarker Content of Review Report on FRMD8P1 Target / Biomarker
FRMD8P1
Other Name(s): FERM domain containing 8 pseudogene 1

FERM Domain Containing 8 Pseudogene 1 Is A Potential Drug Target and Biomarker for Muscle Diseases

The FERM domain containing 8 pseudogen 1 (FRMD8P1) is a protein that is expressed in various tissues and organs, including the brain, heart, and skeletal muscles. It is characterized by the presence of an N-terminal fragment that contains the FERM domain, as well as a C-terminal fragment that contains a repetitive nucleotide sequence.

The FERM domain is a conserved region that is found in a variety of proteins, including transcription factors, DNA-binding proteins, and RNA-binding proteins. It is composed of a nucleotide-rich region that is involved in the regulation of gene expression, as well as a transmembrane region that is involved in the protein's localization and interactions with other cellular components.

FRMD8P1 is a pseudogene, which means that it is a gene that does not encode a functional protein. Instead, it is a remnant of a gene that has been transcribed from DNA, but the gene has not been translated into protein. This is why it is called a \"pseudogene.\"

FRMD8P1 has been identified as a potential drug target due to its involvement in the regulation of muscle growth and development. It has been shown to play a role in the regulation of muscle cell size and number, as well as the maintenance of muscle mass during times of growth and exercise.

In addition to its potential as a drug target, FRMD8P1 is also a potential biomarker for the diagnosis and monitoring of muscle diseases, such as muscle weakness or muscle wasting. As more research is conducted on FRMD8P1 and its role in muscle biology, it is likely that this protein will become a valuable tool for the development of new treatments for a variety of muscle-related conditions.

Overall, the FERM domain containing 8 pseudogene 1 (FRMD8P1) is a promising protein for the development of new drugs and biomarkers for a variety of muscle-related conditions. Further research is needed to fully understand its role in muscle biology and to determine its potential as a drug target.

Protein Name: FERM Domain Containing 8 Pseudogene 1

The "FRMD8P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRMD8P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FRMPD1 | FRMPD2 | FRMPD2B | FRMPD3 | FRMPD4 | FRRS1 | FRRS1L | FRS2 | FRS3 | Fructose-Bisphosphate Aldolase | FRY | FRY-AS1 | FRYL | FRZB | FSBP | FSCB | FSCN1 | FSCN2 | FSCN3 | FSD1 | FSD1L | FSD2 | FSHB | FSHR | FSIP1 | FSIP2 | FSIP2-AS2 | FST | FSTL1 | FSTL3 | FSTL4 | FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2